TREATMENT OUTCOMES OF MEDICAL THERAPY COMBINED WITH PARASPINAL COLLAGEN PEPTIDE INJECTION FOR CERVICOBRACHIAL SYNDROME DUE TO CERVICAL SPONDYLOSIS AT THAI NGUYEN NATIONAL HOSPITAL

Thị Thu Trang Trần1, , Thị Bình Lưu2, Đức Hoàng Đồng1
1 Trường Đại học Y Dược, Đại học Thái Nguyên
2 ở Y tế Thái Nguyên

Main Article Content

Abstract

Objective: This study aimed to evaluate the outcomes of pharmacological treatment combined with paraspinal collagen peptide injection in patients with cervicobrachial syndrome due to cervical spondylosis at Thai Nguyen National Hospital.


Subjects and methods: A prospective, controlled, non-randomized interventional study was conducted in 60 patients divided into two groups: Group A included 29 patients receiving pharmacological treatment combined with a 2-mL paraspinal collagen peptide injection, while Group B included 31 patients receiving pharmacological treatment alone. Patients were followed for 12 weeks.


Results: In Group A, the mean VAS pain score decreased from 5.41 ± 0.83 to 0.55 ± 0.74 and was significantly lower than that in Group B (p < 0.05). The mean NDI score in Group A also decreased from 25.31 ± 7.12 to 6.10 ± 3.28, with a significant between-group difference observed at week 4 (p = 0.048). Good-to-fair outcomes were achieved in 82.8% of patients in Group A compared with 64.5% in Group B. No adverse events were observed in Group A.


Conclusion: Paraspinal collagen peptide injection may provide additional benefits in pain relief and functional improvement, particularly during the early treatment period, with good tolerability. Larger studies are warranted to confirm the additional benefits of this approach.

Article Details

References

1. Bộ Y tế. Hướng dẫn chẩn đoán và điều trị các bệnh cơ xương khớp. Quyết định số 361/QĐ-BYT ngày 25/01/2014. Hà Nội: Bộ Y tế; 2014.
2. Wu AM, Cross M, Elliott JM, et al. Global, regional, and national burden of neck pain, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2024;6:e142-e155. doi:10.1016/S2665-9913(23)00321-1.
3. Plener J, Csiernik B, To D, et al. Conservative management of cervical radiculopathy: a systematic review. Clin J Pain. 2023;39:138-146. doi:10.1097/AJP.0000000000001092.
4. Liang CW, Cheng HY, Lee YH, Liao CD, Huang SW. Efficacy and safety of collagen derivatives for osteoarthritis: a trial sequential meta-analysis. Osteoarthritis Cartilage. 2024;32:574-584. doi:10.1016/j.joca.2023.12.010.
5. Nông Thị Linh, Lưu Thị Bình. Kết quả điều trị nội khoa kết hợp liệu pháp tiêm collagen cạnh cột sống ở bệnh nhân thoát vị đĩa đệm cột sống thắt lưng tại Bệnh viện Trung ương Thái Nguyên. Tạp chí Y học Việt Nam. 2024;544(2). doi:10.51298/vmj.v544i2.11839.
6. Koszela K, Woldańska-Okońska M, Stypińska B, Gasik R. A retrospective analysis of the effectiveness and safety of collagen mesotherapy in the course of chronic cervical myofascial pain syndrome. Biomedicines. 2025;13(8):1893. doi:10.3390/biomedicines13081893.
7. Nguyễn Giang Thanh, Lê Thành Xuân, Đinh Thị Lam. Đánh giá tác dụng điều trị hội chứng cổ vai cánh tay do thoái hóa cột sống cổ bằng thuỷ châm Nucleo C.M.P, điện châm kết hợp kéo giãn cột sống. Tạp chí Y học Việt Nam. 2024;543(1). doi:10.51298/vmj.v543i1.11356.
8. Saltychev M, Pylkäs K, Karklins A, Juhola J. Psychometric properties of Neck Disability Index: a systematic review and meta-analysis. Disabil Rehabil. 2024;46:5415-5431.
9. doi:10.1080/09638288.2024.2304644.